H igh-density lipoprotein (HDL) particles are heterogeneous in structure, having differential effect on their antiatherogenic properties.
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were positively associated with the prevalence of coronary artery disease. 12 High-performance liquid chromatography (HPLC) with gel permeation columns is an alternative method for classifying and quantifying lipoproteins according to particle sizes. 13 This method can provide cholesterol levels of major lipoproteins and their subclasses using a small amount of serum or plasma and measure simultaneously cholesterol levels in each lipoprotein fraction and lipoprotein particle size distribution. The HPLC defines 5 HDL subclasses based on HDL particle diameter size, which is similar to gradient gel electrophoresis and nuclear magnetic resonance methods. 13, 14 Advantages of the HPLC method include its direct cholesterol determination in HDL and HDL subclasses within 16 minutes by using a small amount of plasma (<10 µL). 13, 15 In the present study, a prospective nested case-control study of men and women was conducted in 3 Japanese communities of the Circulatory Risk in Communities Study (CIRCS) using stored serum samples. We applied the HPLC method to assess HDL subclasses and to seek their associations with risk of stroke and its subtypes.
Methods

Surveyed Populations
The present study was an ancillary study of the CIRCS. 16 CIRCS is a dynamic cohort of Japanese men and women aged ≥30 years in 5 communities across Japan, overseen by a research team from the Osaka Medical Center for Health Science and Promotion, Osaka University and the University of Tsukuba. The surveyed populations comprised 13 314 men and women aged 40 to 85 years, who participated in cardiovascular risk surveys between 1985 and 2000 in a mideastern rural community (Kyowa; participants and census population for 40-85 years; n=6829 and n=8557, respectively) and between 1989 and 1998 in northeastern rural community (Ikawa; n=2570 and n=2981, respectively) and a southwest rural community (Noichi; n=3915 and n=7169, respectively). The participation rate in cardiovascular risk surveys among men and women aged 40 to 85 years was 80% in Kyowa, 86% in Ikawa, 55% in Noichi, and 71% for the total population. A 1.0-to 2.0-mL serum sample obtained from each participant was stored at −80°C for 1 to 20 years (median, 10.5 years). Participants with a history of stroke or coronary heart disease (n=510) were excluded from the analyses. The participants were followed up to determine the incidence of stroke occurring by the end of 2005. The Ethics Committee of Osaka University, The University of Tsukuba and the Osaka Medical Center for Health Science and Promotion approved this study.
Surveillance of Stroke and Classification of Stroke Subtypes
Susceptible cases of stroke were ascertained from national insurance claims, ambulance records, death certificates (cases with stroke as the underlying cause of death [International Classification of Diseases, 9th revision: 430-438] were selected), reports by local physicians, and reports by public health nurses and volunteers. To confirm the diagnosis of stroke, we called, visited, or invited the susceptible subjects to participate in annual cardiovascular risk surveys to obtain clinical histories. In addition, physicians obtained medical histories and reviewed medical records, including computed tomograpy/magnetic resonance imaging from local clinics and hospitals. In the case of deaths, histories were obtained from families, and medical records were reviewed.
The diagnosis of stroke was made according to the criteria of the National Survey of Stroke, 17 which requires a constellation of neurological deficits of sudden or rapid onset lasting ≥24 hours or until death. Strokes were classified as intraparenchymal hemorrhage, subarachnoid hemorrhage, or ischemic stroke (lacunar infarction, largeartery occlusive infarction, and embolic infarction) by computed tomograpy/magnetic resonance imaging using standardized criteria. 18 Strokes with negative findings on imaging studies and unclassified strokes were excluded. For each new case of stroke, 1 control subject was selected randomly from the participants with no incident stroke, matched for sex, age (±2 years), community, year of serum storage, and fasting status at serum collection (<8 and ≥8 hours).
Determination of HDL Particle Size
Nonfasting venous blood was collected in 7-to 10-mL plain tubes and allowed to stand for 30 minutes for serum separation. The serum samples were aliquoted immediately and placed on dry ice at survey sites and then stored at −80°C.
Serum lipoprotein analyses were performed by HPLC with gel permeation columns (LipoSEARCH; Skylight-Biotec, Inc., Akita, Japan). 15 By this method, HDL was classified by particle size into 5 subgroups: 13.5 to 15.0 nm (very large HDL), 12.1 nm (large HDL), 10.9 nm (medium HDL), 9.8 nm (small HDL), and 7.6 to 8.8 nm (very small HDL). 13 To simplify data analysis, we grouped these HDL subclasses as follows: S-HDL (very small or small HDL), M-HDL (medium HDL), and L-HDL (large or very large HDL).
Statistical Analysis
The odds ratios and 95% confidence intervals for total stroke and stroke subtype were estimated according to quartiles and 1SD increment of total HDL, S-HDL, M-HDL, and L-HDL cholesterol levels with conditional logistic regression models. Adjustment was made for hypertension status (normal, borderline, and hypertension), body mass index (kg/m 2 ), current alcohol intake (g/d), cigarette smoking status (never, ex-smoker, and current), cholesterol-lowering medication (yes/no), log-transformed triglycerides levels (mmol/L), and serum glucose category (normal, impaired glucose tolerance, and diabetes mellitus). SAS version 9.1.3 was used for the statistical analyses (2-tailed).
Results
Age-adjusted baseline characteristics of the controls according to quartiles of HDL subclasses are shown in Table 1 . Body mass index was inversely associated with total HDL cholesterol and L-HDL, and the prevalence of current smokers was lower with the higher quartiles of L-HDL cholesterol levels. Total HDL cholesterol levels were positively associated with S-HDL, M-HDL, and L-HDL cholesterol levels, whereas triglycerides were inversely associated with total HDL cholesterol, S-HDL, M-HDL, and L-HDL cholesterol levels. Mean blood pressure, mean ethanol intake, and prevalence of hypertensive and glucose abnormality did not vary according to total HDL cholesterol, S-HDL, M-HDL, and L-HDL cholesterol levels. The prevalence of diabetes mellitus was lower with the higher quartiles of total HDL and L-HDL cholesterol levels.
During the follow-up period, we identified 241 incident strokes comprising 155 ischemic strokes (116 lacunar infarctions, 35 large-artery occlusive infarctions, and 11 embolic infarctions) and 86 hemorrhagic strokes (64 intraparenchymal hemorrhages and 22 subarachnoid hemorrhages). Table 2 shows odd ratios and 95% confidence intervals for total stroke and stroke subtypes according to the quartiles and 1SD increment of total HDL, S-HDL, M-HDL, and L-HDL cholesterol levels. We did not show the results for large-artery occlusive infarction, embolic infarctions, and subarachnoid hemorrhage because of small incidence numbers. Total HDL cholesterol levels were inversely associated Adjusted for hypertension status BMI, current alcohol intake, cigarette smoking status, cholesterol-lowering medication, log-transformed triglyceride levels, serum glucose category, and matching for sex, age, community, year of serum stored, and fasting status.
with risk of total stroke and lacunar infarction but not of hemorrhagic stroke. S-HDL cholesterol levels were strongly and inversely associated with risk of total stroke, ischemic stroke, particularly lacunar infarction, and hemorrhagic stroke, specifically intraparenchymal hemorrhage. These associations remained statistically significant after further adjustment for cardiovascular risk factors. Moderate inverse associations were observed between M-HDL cholesterol levels and risk of total stroke and its subtypes. No associations were found between L-HDL cholesterol levels and risk of total stroke or its subtypes.
Discussion
The present study is the first study to show that higher cholesterol levels in small HDL and medium HDL particles were associated with lower risk of total stroke, either ischemic or hemorrhagic stroke even after adjustment for known cardiovascular risk factors and matching variables of age, sex, years of serum storage, fasting status, and community. There was no association between L-HDL cholesterol levels and risk of total stroke and its subtypes. Risk of total stroke was ≈90% lower among persons at the highest quartile of S-HDL cholesterol levels or M-HDL cholesterol levels than among those at the lowest quartile. S-HDL and M-HDL cholesterol levels were not associated with age, sex, blood pressure levels, body mass index, smoking, and diabetes mellitus. Taken together, higher cholesterol levels in S-HDL and M-HDL are suggested to reduce risk of stroke beyond the effects of other conventional risk factors. Small HDL and medium HDL cholesterol levels can be increased by increasing dietary intake of carbohydrate 19 and use of fenofibrate. 20 These nonpharmacological and pharmacological interventions may increase hepatic triglyceride lipase activity that promotes the conversion of large HDL particles into small HDL particles via cholesteryl ester transfer protein.
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Mechanisms for HDL subpopulation in protection against cardiovascular disease are complex and not fully understood. The ATP-binding cassette transporter A1 (ABCA1) mediates the efflux of cellular cholesterol and phospholipids to lipid-poor apolipoproteins. 23, 24 Because smaller HDL particles contained phospholipid and more apoA-1 compared with large HDL particles, they have a larger capacity to remove cholesterol from membranes of peripheral cells, particularly macrophages and form cells. 2 Our result is in line with this mechanism, supporting those subjects with higher cholesterol levels in small HDL or medium HDL particle subclasses may protect against atherosclerosis and atherosclerotic cardiovascular disease. The inverse association between cholesterol levels in smaller HDL particles and risk of cardiovascular disease was observed in the Epic-Norfolk prospective population study, 8 Lopid Coronary Angiography Trial Study 6 , and Caerphilly Study. 7 The ATP-binding cassette transporter G1 (ABCG1) stimulates the cholesterol efflux to larger HDL particles 25 because larger HDL particles are the preferred acceptor of ABCG1-mediated cholesterol efflux. 26 This may explain findings of a previous study that large HDL particles were inversely associated with risk of cardiovascular disease, including myocardial infarction and ischemic stroke in women.
11 ABCA1 mediates cholesterol and phospholipid efflux to lipid-poor apoA-I but not to mature HDL. ABCG1 mediates macrophage cholesterol efflux to mature HDL, which might explain mechanism of the relationship of HDL to atherosclerosis risk. 25 However, a study with mice suggested that both ABCA1 and ABCG1 contribute to macrophage reverse cholesterol transport. That study showed a greater decrease in macrophage reverse cholesterol transport from cells where both ABCA1 and ABCG1 expressions were knocked down than from ABCG1-knockdown cells. 27 Another study also indicated that ABCA1 may lipidate lipidpoor apoA-I to generate nascent HDL, which can then act as acceptor for ABCG1-mediated cholesterol efflux. 28 The present study first showed that cholesterol levels in smaller HDL particles were inversely associated with risk of lacunar infarction. The mechanism for a protective effect of small HDL particles on lacunar infarction is unknown. Antiinflammatory effects of smaller HDL particles 5, 29 may reduce risk of lacunar infarction by inhibiting angionecrosis 30, 31 or microatheroma formation 32 in cerebral vessels. An inverse association was found between smaller HDL cholesterol levels and risk of hemorrhagic stroke, primarily intraparenchymal hemorrhage. One mechanism to explain the protective effect of smaller HDL particles might be their enriched apolipoprotein and enzymes with antioxidative activities. 4 Reduced LDL oxidation may contribute to inhibition of microatheroma formation in small cerebral vessels. 31, 33, 34 The strength of the present study is the large number of strokes confirmed by imaging studies, which allowed investigation of the association between S-HDL, M-HDL, and L-HDL cholesterol levels and risk of total stroke and its subtypes. There are several limitations. First, we used frozen serum to estimate HDL cholesterol levels and did not examine long-term changes in HDL cholesterol levels in stored serum samples. A previous study on frozen storage (−70°C) of serum samples for up to 7 years showed no significant change in HDL cholesterol. 35 Second, the frozen serum samples used in the present study had been thawed once. However, a previous study reported that freezing and thawing of HDL have no effect on HDL particle size. 36 In conclusion, the present study showed that cholesterol levels in small HDL and medium HDL particles were inversely associated with risks of total stroke, either ischemic or hemorrhagic stroke, whereas those in large HDL particles were not associated with risk of total stroke or any subtypes.
